Registration - In-house Corporation

Merck Canada Inc. / Marwan Akar, PRESIDENT

Registration Information

In-house Corporation name: Merck Canada Inc.
Previous in-house corporation names
Responsible Officer Name: Marwan Akar, PRESIDENT
Responsible Officer Change History
Initial registration start date: 2001-02-01
Registration status: Active
Registration Number: 950084-12241

Associated Communications

Total Number of Communication Reports: 194

Monthly communication reports in the last 6 months: 5

Version 11 of 43 (2009-11-02 to 2010-04-14)

Registration versions:

Version 11 of 43 (2009-11-02 to 2010-04-14)

Lobbying Information

Subject Matters

Constitutional Issues
Consumer Issues
Health
Industry
Intellectual Property
Internal Trade
International Relations
International Trade
Justice and Law Enforcement
Science and Technology
Taxation and Finance

Subject matters added through a monthly communication report

National Immunization Strategy Program Funding

Subject Matter Details

Legislative Proposal, Bill or Resolution

Canada's Food and Consumer Safety Action Plan proposes a series of initiatives to modernize and strengthen Canada's safety system for food, health and consumer products. Merck Frosst Canada seeking to ensure that Canada's safety system for medicines ensures safe and effective medicines for Canadians in a timely manner, consistent with other jurisdictions.

Policies or Program

Health Canada's Blue Print for Renewal: Transforming Canada's Approach to Regulating Health Products and Food to renew the process for approving drugs. Merck Frosst Canada seeking to ensure that Canada's safety system for medicines ensures safe and effective medicines for Canadians in a timely manner, consistent with other jurisdictions.
Patented Medicine Prices Review Board (PMPRB) Pricing Guidelines used by the PMPRB to ensure that prices of patented medicines sold in Canada are not excessive. Merck Frosst Canada seeking to ensure PMPRB Guidelines reflect their mandate of ensuring prices are non-excessive, while ensuring an attractive climate for pharmaceutical research.
The Government's Science and Technology (S&T) Strategy announced in May 2007 which encourages a more competitive Canadian economy and improved quality of life for Canadians through science and technology. Merck Frosst seeking to ensure S&T Strategy encourages a more competitive environment for biopharmaceutical innovation in Canada.
The National Pharmaceutical Strategy as agreed to by First Ministers in 2004, with a focus on options for catastrophic pharmaceutical coverage. Merck Frosst Canada seeking to ensure that Canadians' ability to access the medicines they need is increased.

Policies or Program, Regulation

Canada's Access to Medicine Regime (CAMR) and its Regulations which provide a framework within which eligible developing countries can import less expensive generic versions of patented drugs and medical devices. Merck Frosst Canada seeking to ensure that those threatened by serious diseases have timely access to medicines for the diseases and that a research climate that will help to produce cures for other diseases is maintained. Canada's Access to Medicines Regime Regulations.

Regulation

Health Canada Health Products and Foods Branch Cost Recovery Proposal for Human Drug User Fees. Merck Frosst Canada seeking to ensure that renewed user fees adequately fund a safe and efficient review process. Food and Drug Regulation.
Patented Medicine Prices Review Board (PMPRB) Regulations identifying information to be reported to the PMPRB. Merck Frosst Canada seeking to ensure that the information being collected is consistent with PMPRB's mandate to prevent excessive pricing while ensuring an attractive climate for pharmaceutical research.
Patented Medicines (Notice of Compliance) Regulations which seek to balance patent rights and cost savings. Merck Frosst Canada seeking to ensure that patent rights are respected and are internationally competitive.

Communication Techniques

Written communication
Oral communication
Grass-roots communication

Government Institutions

Canadian International Development Agency (CIDA)
Canadian International Trade Tribunal (CITT)
Federal Office of Regional Development – Quebec (FORD[Q])
Finance Canada (FIN)
Foreign Affairs and International Trade Canada (DFAITC)
Health Canada (HC)
Industry Canada
Justice Canada (JC)
Members of the House of Commons
National Research Council (NRC)
Patented Medicine Prices Review Board (PMPRB)
Prime Minister's Office (PMO)
Privy Council Office (PCO)
Procurement Review Board of Canada (PRB)
Public Health Agency of Canada (PHAC)
Public Safety and Emergency Preparedness Canada (PSEPC)
Senate of Canada
Solicitor General Canada (SGC)
Status of Women Canada (SWC)
Treasury Board Of Canada Secretariat (TBS)

In-house Corporation Details

Description of activities

At Merck Frosst, patients come first. Merck Frosst Canada Ltd. is a research-driven pharmaceutical company. Merck Frosst discovers, develops and markets a broad range of innovative medicines to improve human health. The Merck Frosst Centre for Therapeutic Research, one of the largest biomedical research facilities in Canada, has the mandate to discover new therapies for the treatment of respiratory diseases, inflammatory diseases, diabetes, osteoporosis and hypertension. Merck Frosst is one of the top 20 R&D investors in Canada, with an investment of $114 million in 2006. The Company is committed to fostering partnerships to deliver the most valuable health outcomes for Canadian patients. Merck Frosst is a recognized leader in the treatment of asthma, osteoporosis, HIV/AIDS, glaucoma, prostate disease, migraines and infectious diseases. The Company also markets an extensive line of cardiovascular products for high blood pressure, elevated cholesterol and heart failure as well as a broad range of vaccines. Based in Montréal, Quebec, Merck Frosst employs nearly 1,600 people including more than 300 of the world's leading scientific personnel. It is also firmly committed to science education and sponsors a number of programs designed to spark young people's interest in science. More information about Merck Frosst is available at http://www.merckfrosst.com

Responsible officer name and position during the period of this registration

Carlos Dourado, PRESIDENT

Government funding

No government funding was received during the last completed financial year.

In-house Corporation Contact Information

Address:
16711 TransCanada Highway
Kirkland, QC H9H 3L1
Canada

Telephone number: 514-426-7300

Parent Company Information

MERCK FROSST COMPANY
- 1959 Upper Water Street
  Suite 900
  Halifax, NS B3J 2X2
  Canada

Subsidiary Beneficiary Information

MERCK FROSST CANADA LTD. does not have any subsidiaries that could have a direct interest in the outcome of the undertaking

Lobbyists Details

Senior Officers whose lobbying activities represent less than 20% of their Duties

Michel Cimon, Executive Director, Medical Research | No public offices held
Richard Garant, Executive Director, Business Unit 4 | No public offices held
Dawn Graham, President | No public offices held
Bernard Houde, Vice President, Legal | No public offices held
Gregg Szabo, Executive Director, Policy and Reimbursement | No public offices held
Joseph P. Vacca, Executive Director and Itnerim Site Head | No public offices held

Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties

Kathy Armstrong, Manager, Policy - Health - Ontario | No public offices held
Christian Blouin, Director, Public Health | No public offices held
Louis Lamarche, National Manager - Public Health | No public offices held
Robert Livingston, Director, Federal Government Affairs | No public offices held
Jean-Pierre Metabanzoulou, Senior Manager, Compliance and Audits | No public offices held
Wendy Morton, Manager, Policy Planning | No public offices held
Sandra Wainwright, Director - Regulatory Affairs | No public offices held

Merck Canada Inc.

The following names have been used on or after July 2, 2008

The following names have been used on or after July 2, 2008
Name	From	To
Merck Canada Inc.	2024-04-04	current
Merck Canada Inc.	2011-01-01	2024-04-04
MERCK FROSST CANADA LTD.	2008-07-08	2011-01-01

The following names have been used before July 2, 2008

MERCK FROSST CANADA LTD.
MERCK FROSST CANADA INC

Merck Canada Inc.

Responsible Officer History
Responsible Officer Name	From (YYYY-MM-DD)	To (YYYY-MM-DD)
Marwan Akar	2021-09-17	Current
Anna Van Acker	2017-12-14	2021-09-17
Chirfi Guindo	2014-10-01	2017-12-14
Thomas Cannell	2013-01-01	2014-10-01
Cyril Schiever	2011-07-01	2013-01-01
Carlos Dourado	2009-11-02	2011-07-01
DAWN GRAHAM	2001-02-01	2009-11-02

Marwan Akar, PRESIDENT (Corporation)

Learn more...

Registrants are required to submit a monthly communication report for each oral and arranged communication with a designated public office holder. The name of the most senior paid officer (i.e. the registrant) will appear on all in-house monthly communication reports, whether or not he/she participated in the communication.

Note: Monthly Communication Reports are due on the 15^th day of each month for communications that took place in the previous month.

Results below are sorted by posted date, beginning with the most recent.

Results 1-194 of 194

Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Blaine Calkins, Member of Parliament | House of Commons
Subject Matter of the communication: Health, Industry, Research and Development
Communication date: 2024-05-25
Posted date: 2024-06-14
Communication number: 12241-607736 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Tom Kmiec, Member of Parliament | House of Commons
Subject Matter of the communication: Health, Industry, Research and Development
Communication date: 2024-05-24
Posted date: 2024-06-14
Communication number: 12241-607735 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Dr. Stephen Ellis, Member of Parliament | House of Commons
Subject Matter of the communication: Health, Industry, Research and Development
Communication date: 2024-05-23
Posted date: 2024-06-14
Communication number: 12241-607734 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Marilou McPhedran, Senator | Senate of Canada
Subject Matter of the communication: Health, Industry, Research and Development
Communication date: 2024-05-22
Posted date: 2024-06-14
Communication number: 12241-607737 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Rodrigo Arancibia, Director | Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Industry, Research and Development
Communication date: 2024-04-04
Posted date: 2024-05-13
Communication number: 12241-602791 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Rodrigo Arancibia, Director | Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Industry, Research and Development, Science and Technology
Communication date: 2024-02-15
Posted date: 2024-03-13
Communication number: 12241-596467 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- F. Gigi Osler, Senate of Canada | Hororable Senator | Senate of Canada
- Mohamad Iqbal Ravalia, Honorable Senator | Senate of Canada
Subject Matter of the communication: Health, Industry
Communication date: 2023-11-08
Posted date: 2023-12-15
Communication number: 12241-588142 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Simon Kennedy, Office of Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
- Ritu Banerjee, Assistant Deputy Minister | Director General's Office | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health, Industry, Economic Development
Communication date: 2023-11-08
Posted date: 2023-12-15
Communication number: 12241-588140 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Christopher Evelyn, MInsiter of Families | Employment and Social Development Canada (ESDC)
- Corey Tochor, Member of Parliament | House of Commons
- Connor MacDonald, Policy Advisor | House of Commons
- Anton Lori, Party Leader | House of Commons
- sharon burey, Honorable Senator | Senate of Canada
Subject Matter of the communication: Health, Industry
Communication date: 2023-11-07
Posted date: 2023-12-15
Communication number: 12241-588139 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Stephen Ellis, Member house of Commons | House of Commons
- Valerie Bradford, Member of Parliament | House of Commons
- Chandra Arya, Member of House of Commons | House of Commons
- Yash Nanda, Policy Advisor | Finance Canada (FIN)
Subject Matter of the communication: Health
Communication date: 2023-11-06
Posted date: 2023-12-15
Communication number: 12241-588141 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Alan Thom, Sr Manager, Vaccine Supply and Assurance | Public Health Agency of Canada (PHAC)
- Milan Patel, Director, Vaccine Supply & Assurance | Public Health Agency of Canada (PHAC)
- Michael Pignat, Manager, Procurement | Public Health Agency of Canada (PHAC)
- David Hennigar, Senior Policy Analyst | Public Health Agency of Canada (PHAC)
Subject Matter of the communication: Health, Industry
Communication date: 2023-10-11
Posted date: 2023-11-10
Communication number: 12241-581886 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Matthew Tunis, Executive Secretary | National Advisory Committee on Immunization | Health Canada (HC)
Subject Matter of the communication: Health, Industry
Communication date: 2023-09-22
Posted date: 2023-10-11
Communication number: 12241-578130 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Ritu Banerjee, Assistant Deputy Minister | Director General's Office | Innovation, Science and Economic Development Canada (ISED)
- Rodrigo Arancibia, Director | Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health, Economic Development, Research and Development
Communication date: 2023-09-05
Posted date: 2023-10-11
Communication number: 12241-578131 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Dr. Stephen Ellis, Member of Parliament | House of Commons
Subject Matter of the communication: Health, Industry
Communication date: 2023-08-03
Posted date: 2023-09-13
Communication number: 12241-576214 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- ritu Banerjee, Assistant deputy Minister | Life Science & Biomanufacturing Branch | Innovation, Science and Economic Development Canada (ISED)
- Rodrigo Arancibia, Director | Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Industry, Research and Development, Science and Technology
Communication date: 2023-06-06
Posted date: 2023-07-12
Communication number: 12241-571595 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Robert Kitchen, Member of Parlilament | House of Commons
Subject Matter of the communication: Health, Industry, Intellectual Property, Economic Development, Research and Development
Communication date: 2023-04-25
Posted date: 2023-05-15
Communication number: 12241-565368 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Majid Jowhari, Member of Parliament | House of Commons
Subject Matter of the communication: Health, Industry, Intellectual Property, Economic Development, Research and Development, Science and Technology
Communication date: 2023-04-20
Posted date: 2023-05-15
Communication number: 12241-565367 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Matthew Tunis, Executive Secretary, National Advisory Committee on Immunization | Public Health Agency of Canada (PHAC)
Subject Matter of the communication: Industry
Communication date: 2023-03-14
Posted date: 2023-04-11
Communication number: 12241-561432 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Hilary Peirce, Senior Policy Advisor | Treasury Board Of Canada Secretariat (TBS)
Subject Matter of the communication: Health, Intellectual Property, Economic Development, Research and Development, Science and Technology
Communication date: 2022-11-30
Posted date: 2022-12-12
Communication number: 12241-549651 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Bianca Hossain, Sr Special Assistant | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health, Industry, Economic Development, Research and Development, Science and Technology
Communication date: 2022-10-27
Posted date: 2022-11-11
Communication number: 12241-546071 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- david Norris, Acting Deputy Director | Intellectual Property Trade Policy | Global Affairs Canada (GAC)
Subject Matter of the communication: Intellectual Property
Communication date: 2022-10-19
Posted date: 2022-11-11
Communication number: 12241-546070 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Nancy Hamzawi, Assistant Deputy Minister | Health Canada (HC)
- Supriya Sharma, Chief Medical Advisor | Health Canada (HC)
Subject Matter of the communication: Health, Research and Development, Science and Technology
Communication date: 2022-07-22
Posted date: 2022-08-09
Communication number: 12241-539371 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Nancy Hamzawi, Assistant Deputy Minister | Health Canada (HC)
- Supriya Sharma, Chief Medical Advisor | Health Canada (HC)
Subject Matter of the communication: Health, Research and Development, Science and Technology
Communication date: 2022-07-11
Posted date: 2022-08-09
Communication number: 12241-539370 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Michelle Boudreau, Executive Director | Office of Pharmaceutical Management Strategies | Health Canada (HC)
- samir khan, Sr Advisor for Employment | Employment and Social Development Canada (ESDC)
Subject Matter of the communication: Health, Industry, Research and Development, Science and Technology
Communication date: 2022-06-24
Posted date: 2022-07-12
Communication number: 12241-537205 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Jean-Sebastien Bock, Director of Policy | Office of the Minister of Health | Health Canada (HC)
- Sandenga Yeba, Senior Policy Advisor | Minister's Office | Health Canada (HC)
Subject Matter of the communication: Health, Industry, Research and Development, Science and Technology
Communication date: 2022-06-21
Posted date: 2022-07-12
Communication number: 12241-537203 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Nancy Hamzawi, Assistant Deputy Minister | Health Canada (HC)
- Supriya Sharma, Chief Medical Advisor | Health Canada (HC)
Subject Matter of the communication: Health, Industry, Research and Development, Science and Technology
Communication date: 2022-06-20
Posted date: 2022-07-12
Communication number: 12241-537201 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Stephen Lucas, Deputy Minister | Health Canada (HC)
- Nancy Hamzawi, Assistant Deputy Minister | Health Canada (HC)
- Supriya Sharma, Chief Medical Advisor | Health Canada (HC)
Subject Matter of the communication: Health, Industry, Research and Development, Science and Technology
Communication date: 2022-06-07
Posted date: 2022-07-12
Communication number: 12241-537196 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Jamie Kippen, Chief of Staff | Minister's Office | Health Canada (HC)
Subject Matter of the communication: Health, Industry, Research and Development, Science and Technology
Communication date: 2022-06-03
Posted date: 2022-07-12
Communication number: 12241-537194 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Rodrigo Arancibia, Director | Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health, Industry, Economic Development, Research and Development, Science and Technology
Communication date: 2022-05-19
Posted date: 2022-06-13
Communication number: 12241-534120 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Stephen Lucas, Deputy Minister | Health Canada (HC)
- Nancy Hamzawi, Assistant Deputy Minister | Health Canada (HC)
- Supriya Sharma, Chief Medical Advisor | Health Canada (HC)
Subject Matter of the communication: Health, Industry, Research and Development, Science and Technology
Communication date: 2022-05-05
Posted date: 2022-06-13
Communication number: 12241-534116 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- michelle Mujoomdar, Dir Office of Pharmaceutical Mgmt/Strategy | Health Canada (HC)
Subject Matter of the communication: Health, Industry, Research and Development, Science and Technology
Communication date: 2022-04-25
Posted date: 2022-05-16
Communication number: 12241-532034 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Jamie Kippen, Chief of Staff | Minister's Office | Health Canada (HC)
Subject Matter of the communication: Health, Industry, Research and Development, Science and Technology
Communication date: 2022-04-05
Posted date: 2022-05-16
Communication number: 12241-532033 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Yash Nanda, Policy Advisor | Minister of Finance | House of Commons
Subject Matter of the communication: Health
Communication date: 2022-03-31
Posted date: 2022-04-14
Communication number: 12241-528921 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Jamie Kippen, Chief of Staff | Minister's Office | Health Canada (HC)
Subject Matter of the communication: Industry, Research and Development, Science and Technology
Communication date: 2022-03-28
Posted date: 2022-04-14
Communication number: 12241-528918 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Maria Campbell, Minister Exempt Staff | Office of the Minister of Seniors | Employment and Social Development Canada (ESDC)
Subject Matter of the communication: Health
Communication date: 2022-03-23
Posted date: 2022-04-14
Communication number: 12241-528919 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Darryl patterson, Director General | Innovation, Science and Economic Development Canada (ISED)
- Rodrigo Arancibia, Director | Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health, Industry, Economic Development, Research and Development, Science and Technology
Communication date: 2022-03-22
Posted date: 2022-04-14
Communication number: 12241-528914 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Jamie Kippen, Chief of Staff | Minister's Office | Health Canada (HC)
Subject Matter of the communication: Health, Industry, Research and Development, Science and Technology
Communication date: 2022-03-21
Posted date: 2022-04-14
Communication number: 12241-528911 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Michelle Boudreau, Executive Director | Strategic Policy Branch | Health Canada (HC)
Subject Matter of the communication: Industry
Communication date: 2022-03-16
Posted date: 2022-04-14
Communication number: 12241-528910 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Stephen Lucas, Deputy Minister | Health Canada (HC)
- Nancy Hamzawi, Assistant Deputy Minister | Health Canada (HC)
Subject Matter of the communication: Health, Industry, Research and Development, Science and Technology
Communication date: 2022-03-03
Posted date: 2022-04-14
Communication number: 12241-528907 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Rodrigo Arancibia, Director | Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health, Industry, Economic Development, Research and Development, Science and Technology
Communication date: 2022-03-02
Posted date: 2022-04-14
Communication number: 12241-528904 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Isa Topbas, Special Assistant | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health, Industry, Economic Development, Research and Development, Science and Technology
Communication date: 2022-02-24
Posted date: 2022-03-11
Communication number: 12241-524996 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Rodrigo Arancibia, Director | Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health, Industry, Economic Development, Research and Development, Science and Technology
Communication date: 2022-02-22
Posted date: 2022-03-11
Communication number: 12241-524995 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Rodrigo Arancibia, Director | Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health, Industry, Economic Development, Research and Development, Science and Technology
Communication date: 2022-02-07
Posted date: 2022-03-11
Communication number: 12241-524994 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Isa Topbas, Special Assistant | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health, Industry, Research and Development, Science and Technology
Communication date: 2022-02-07
Posted date: 2022-03-11
Communication number: 12241-524991 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Mary-Rose Brown, Senior Policy Advisor | Minister's Office | Finance Canada (FIN)
Subject Matter of the communication: Economic Development
Communication date: 2022-02-03
Posted date: 2022-03-11
Communication number: 12241-525004 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- jacqueline Arthur, Executive Director | Public Health Agency of Canada (PHAC)
Subject Matter of the communication: Health, Industry
Communication date: 2022-01-28
Posted date: 2022-02-08
Communication number: 12241-521288 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Stephen Lucas, Deputy Minister | Health Canada (HC)
Subject Matter of the communication: Health, Industry
Communication date: 2022-01-24
Posted date: 2022-02-08
Communication number: 12241-521287 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Supriya Sharma, Chief Medical Advisor | Health Canada (HC)
Subject Matter of the communication: Health, Industry
Communication date: 2022-01-18
Posted date: 2022-02-08
Communication number: 12241-521286 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Kirsty Duncan, Member of Parliament | House of Commons
Subject Matter of the communication: Health, Industry
Communication date: 2021-12-17
Posted date: 2022-01-12
Communication number: 12241-519185 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Michelle Boudreau, Executive Director | Strategic Policy Branch | Health Canada (HC)
Subject Matter of the communication: Industry
Communication date: 2021-12-16
Posted date: 2022-01-12
Communication number: 12241-519184 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Isa Topbas, Regional Director Advisor Ontario & Atlantic | Office of Minister of Innovation | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health, Industry
Communication date: 2021-12-09
Posted date: 2022-01-12
Communication number: 12241-519183 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Sarah Hussaini, Chief of Staff | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health, Industry
Communication date: 2021-11-27
Posted date: 2021-12-15
Communication number: 12241-517791 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Arianne Reza, Assistant Deputy Minister | PSPC | Public Services and Procurement Canada (PSPC)
- Michael Mills, Assistant Deputy Minister | Procurement Canada | Health Canada (HC)
Subject Matter of the communication: Health, Industry
Communication date: 2021-11-26
Posted date: 2021-12-15
Communication number: 12241-517790 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Stephen Lucas, Deputy Minister | Ministry of Health | Health Canada (HC)
- Pierre Sabourin, Assistant Deputy Minister of Health | Health Canada (HC)
Subject Matter of the communication: Health
Communication date: 2021-11-18
Posted date: 2021-12-15
Communication number: 12241-517789 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Rodrigo Arancibia, Manufacturing Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health, Industry
Communication date: 2021-11-12
Posted date: 2021-12-15
Communication number: 12241-517788 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Levent Ozmutlu, Director General | Public Services and Procurement Canada (PSPC)
- Bersabel Ephram, Director General | PSPC | Public Health Agency of Canada (PHAC)
- Niyi Lawuyi, Advisor to Director General | PHAC | Public Health Agency of Canada (PHAC)
Subject Matter of the communication: Health, Industry
Communication date: 2021-11-12
Posted date: 2021-12-15
Communication number: 12241-517786 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Levent Ozmutlu, Director General | Public Services and Procurement Canada (PSPC)
- Michael Mills, Assistant Deputy Minister | Procurement Canada | Health Canada (HC)
Subject Matter of the communication: Health, Industry
Communication date: 2021-11-11
Posted date: 2021-12-15
Communication number: 12241-517785 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Rodrigo Arancibia, Manufacturing Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health, Industry
Communication date: 2021-11-10
Posted date: 2021-12-15
Communication number: 12241-517784 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Bill Matthews, Deputy Minister | PSPC | Public Services and Procurement Canada (PSPC)
- Arianne Reza, Assistant Deputy Minister | PSPC | Public Services and Procurement Canada (PSPC)
- Michael Mills, Assistant Deputy Minister | Procurement Canada | Health Canada (HC)
Subject Matter of the communication: Health, Industry
Communication date: 2021-11-08
Posted date: 2021-12-15
Communication number: 12241-517782 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Rodrigo Arancibia, Manufacturing Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health, Industry
Communication date: 2021-11-05
Posted date: 2021-12-15
Communication number: 12241-517781 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Michael Mills, Assistant Deputy Minister | Procurement Canada | Health Canada (HC)
Subject Matter of the communication: Health
Communication date: 2021-11-05
Posted date: 2021-12-15
Communication number: 12241-517780 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Stephen Lucas, Deputy Minister | Ministry of Health | Health Canada (HC)
Subject Matter of the communication: Health
Communication date: 2021-11-03
Posted date: 2021-12-15
Communication number: 12241-517779 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Michelle Boudreau, Executive Director | Strategic Policy Branch | Health Canada (HC)
- Lawrence Cheung, Management Strategies | Strategic Policy Branch | Health Canada (HC)
Subject Matter of the communication: Health, Industry
Communication date: 2021-10-22
Posted date: 2021-11-12
Communication number: 12241-515408 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Pierre Sabourin, Assistant Deputy Minister of Health | Health Canada (HC)
Subject Matter of the communication: Health, Industry
Communication date: 2021-10-14
Posted date: 2021-11-12
Communication number: 12241-515407 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Jacqueline Arthur, Executive Director | Health Canada (HC)
Subject Matter of the communication: Health, Industry
Communication date: 2021-10-13
Posted date: 2021-11-12
Communication number: 12241-515406 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Michael Mills, Assistant Deputy Minister | Procurement Canada | Health Canada (HC)
- howard njoo, Deputy Chief Public Health Officer | Health Canada (HC)
Subject Matter of the communication: Health, Industry
Communication date: 2021-10-08
Posted date: 2021-11-12
Communication number: 12241-515405 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Pierre Sabourin, Assistant Deputy Minister of Health | Health Canada (HC)
Subject Matter of the communication: Health
Communication date: 2021-10-06
Posted date: 2021-11-12
Communication number: 12241-515404 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Rodrigo Arancibia, Manufacturing Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
- Benoit Leduc, Manager | Industry Sector | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Industry, Economic Development
Communication date: 2021-10-05
Posted date: 2021-11-12
Communication number: 12241-515403 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- lawrence cheung, Office of Pharmaceutical Management Strategies | Strategic Policy Branch | Health Canada (HC)
- Leoma Kwong, Office of Pharmaceutical Management Stratgies | Strategic Policy Branch | Health Canada (HC)
Subject Matter of the communication: Health, Industry, Research and Development
Communication date: 2021-08-13
Posted date: 2021-09-10
Communication number: 12241-513753 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Michael Roche, Issues Manager | Office of the Leader NDP | House of Commons
Subject Matter of the communication: Health, Industry, Research and Development
Communication date: 2021-07-27
Posted date: 2021-08-10
Communication number: 12241-512275 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Patrick Hum, Manufacturing Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
- Rodrigo Arancibia, Manufacturing Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health, Industry, Research and Development
Communication date: 2021-07-15
Posted date: 2021-08-10
Communication number: 12241-512273 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Francis Scarpaleggia, Member of Parliament | House of Commons
Subject Matter of the communication: Health, Industry, Research and Development
Communication date: 2021-07-12
Posted date: 2021-08-10
Communication number: 12241-512272 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- marta Cabral, Special Advisor | Leader of Green Party | House of Commons
- Isabelle Nimick, Intern | Green Party | House of Commons
Subject Matter of the communication: Health, Industry, Research and Development
Communication date: 2021-07-08
Posted date: 2021-08-10
Communication number: 12241-512274 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Kathryn Nowers, Director Policy, Office of the Minister of Health | Health Canada (HC)
Subject Matter of the communication: Health, Industry, Research and Development
Communication date: 2021-07-02
Posted date: 2021-08-10
Communication number: 12241-512271 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Erin O'Toole, Member of Parliament | House of Commons
Subject Matter of the communication: Health, Industry, Intellectual Property, Economic Development, Research and Development
Communication date: 2021-06-21
Posted date: 2021-07-13
Communication number: 12241-510218 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Pierre Sabourin, Assistant Deputy Minister of Health | Health Canada (HC)
Subject Matter of the communication: Health, Industry, Research and Development
Communication date: 2021-06-16
Posted date: 2021-07-13
Communication number: 12241-510217 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Pierre Sabourin, Assistant Deputy Minister of Health | Health Canada (HC)
Subject Matter of the communication: Health, Industry, Intellectual Property, Research and Development
Communication date: 2021-06-15
Posted date: 2021-07-13
Communication number: 12241-510216 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Stephanie Muccilli, Minister of Seniors | Employment and Social Development Canada (ESDC)
- Isabel Davis, Intern | Ministry of Seniors | Employment and Social Development Canada (ESDC)
Subject Matter of the communication: Health
Communication date: 2021-06-02
Posted date: 2021-07-13
Communication number: 12241-510213 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Michelle Boudreau, Executive Director | Strategic Policy Branch | Health Canada (HC)
- Lawrence Cheung, Associate Executive Director | Strategic Policy Branch | Health Canada (HC)
Subject Matter of the communication: Health, Industry, Intellectual Property, Economic Development, Research and Development
Communication date: 2021-05-28
Posted date: 2021-06-15
Communication number: 12241-508472 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Adam Doane, Therapeutics Products Directorate | Health Products and Food branch | Health Canada (HC)
- John Patrick Stewart, Director General | Health Products and Food branch | Health Canada (HC)
- Mary Coughlin, Senior Regulatory Policy Advisor | Health Products and Food branch | Health Canada (HC)
- Evelyn Soo, Director | Health Products and Food branch | Health Canada (HC)
- Krista Apse, Executive Director | Infectious Disease Prevention and Control Branch | Public Health Agency of Canada (PHAC)
- Benoit Leduc, Manager | Industry Sector | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health, Industry, Intellectual Property, Economic Development, Research and Development
Communication date: 2021-05-27
Posted date: 2021-06-15
Communication number: 12241-508479 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Holly Duggan, Researcher | MP Officer | Health Canada (HC)
- Alexander MacDonald, Researcher | MP Officer | Health Canada (HC)
Subject Matter of the communication: Health, Industry, Intellectual Property, Economic Development, Research and Development
Communication date: 2021-05-27
Posted date: 2021-06-14
Communication number: 12241-507822 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Paul Halucha, Assistant Secretary to the Cabinet | Office of the deputy secretary of the cabinet | Privy Council Office (PCO)
- Jeff Waring, Director General | Office of the deputy secretary of the cabinet | Privy Council Office (PCO)
Subject Matter of the communication: Health, Industry, Intellectual Property, Economic Development, Research and Development
Communication date: 2021-05-06
Posted date: 2021-06-14
Communication number: 12241-507831 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Aneil Jaswal, Senior Policy Advisor | Minister's Office | Finance Canada (FIN)
Subject Matter of the communication: Health, Industry, Intellectual Property, Economic Development, Research and Development
Communication date: 2021-04-29
Posted date: 2021-05-12
Communication number: 12241-504156 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- François-Philippe Champagne, Minister of International Trade | Minister's Office | Global Affairs Canada (GAC)
- Amanda Woodley, Policy Advisor | Minister's Office | Global Affairs Canada (GAC)
Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
Communication date: 2021-04-29
Posted date: 2021-05-10
Communication number: 12241-503825 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Pierre Sabourin, Assistant Deputy Minister of Health | Health Canada (HC)
Subject Matter of the communication: Health, Industry, Intellectual Property, Economic Development, Research and Development
Communication date: 2021-03-31
Posted date: 2021-04-09
Communication number: 12241-500916 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Holly Duggan, Stakeholder Relations Advisor, Office of the Leader of Opposition | House of Commons
Subject Matter of the communication: Health, Industry, Intellectual Property, Economic Development, Research and Development
Communication date: 2021-03-30
Posted date: 2021-04-09
Communication number: 12241-500921 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- michael Paramathasan, Senior Policy Advisor, President of the Treasury Board | Health Canada (HC)
Subject Matter of the communication: Health, Industry, Intellectual Property, Economic Development, Research and Development
Communication date: 2021-03-30
Posted date: 2021-04-09
Communication number: 12241-500920 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Kathryn Nowers, Director Policy, Office of the Minister of Health | Health Canada (HC)
- Helen Gao, Policy Advisor, Office of the Minister | Health Canada (HC)
Subject Matter of the communication: Health, Industry, Intellectual Property, Economic Development, Research and Development
Communication date: 2021-03-19
Posted date: 2021-04-09
Communication number: 12241-500918 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Chris D'entremont, Member of Parliament | House of Commons
Subject Matter of the communication: Health, Industry, Intellectual Property, Economic Development, Research and Development
Communication date: 2021-02-25
Posted date: 2021-03-15
Communication number: 12241-497702 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Celine Caira, Policy advisor, Innovation, Science and economic Development Canada | Innovation, Science and Economic Development Canada (ISED)
- Amanda Woodley, Policy advisor, Innovation, Science and economic Development Canada | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health, Industry, Intellectual Property, Economic Development, Research and Development
Communication date: 2021-02-19
Posted date: 2021-03-15
Communication number: 12241-497708 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Sheryl Groeneweg, Director General | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health
Communication date: 2020-09-25
Posted date: 2020-10-14
Communication number: 12241-484304 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Pierre Sabourin, Assistant Deputy Minister | Health Canada | Health Canada (HC)
Subject Matter of the communication: Health
Communication date: 2020-03-20
Posted date: 2020-04-17
Communication number: 12241-471312 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Ben Chin, Senior Advisor | Prime Minister's Office (PMO)
Subject Matter of the communication: Health
Communication date: 2020-01-27
Posted date: 2020-02-13
Communication number: 12241-464169 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Jason Easton, Chief of staff | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health
Communication date: 2020-01-13
Posted date: 2020-02-13
Communication number: 12241-464166 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Pierre Sabourin, Assistant Deputy Minister of Health | Health Canada | Health Canada (HC)
Subject Matter of the communication: Health
Communication date: 2019-11-19
Posted date: 2019-12-19
Communication number: 12241-462036 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- David Lee, Chief Regulatory Officer for Health Canada | Health Canada | Health Canada (HC)
Subject Matter of the communication: Health
Communication date: 2019-10-08
Posted date: 2019-11-12
Communication number: 12241-460451 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Lars Wessman, Senior Special Assistant | House of Commons
Subject Matter of the communication: Health
Communication date: 2019-09-06
Posted date: 2019-10-18
Communication number: 12241-460265 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Francis Scarpaleggia, Member of parliment | House of Commons
Subject Matter of the communication: Health
Communication date: 2019-08-08
Posted date: 2019-09-18
Communication number: 12241-459815 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Jordan Leichnitz, Advisor, Office of NDP Leader | Parliamentary Affairs | House of Commons
- Jonathan Gauvin, Advisor, Office of NPD Leader | House of Commons
Subject Matter of the communication: Health
Communication date: 2019-07-25
Posted date: 2019-08-13
Communication number: 12241-458519 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Marilyn Gladu, Member of Parliament | Conservative Party | House of Commons
- Alice Wong, Member of Parliament | Conservative Party: Indigeneous and Northern Affairs Canada | House of Commons
- Dan Albas, Member of Parliament | Conservative Party | House of Commons
Subject Matter of the communication: Health
Communication date: 2019-06-05
Posted date: 2019-07-15
Communication number: 12241-456881 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Dylan Marando, Director of Policy | Office of the Minister of Family, Children and Social Development | Employment and Social Development Canada (ESDC)
- Sebastien Beaupré-Huot, Special Assistant, Operations and Stakeholder Relations Coordination | Office of the Minister of Family, Children and Social Developemtn | Employment and Social Development Canada (ESDC)
Subject Matter of the communication: Health, Industry, Labour, Science and Technology
Communication date: 2019-05-29
Posted date: 2019-06-12
Communication number: 12241-454975 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Leslie Church, Chief of Staff to Minister Monsef, Minister of International Development and Minister of Women and Gender Equity | Prime Minister's Office (PMO)
Subject Matter of the communication: Health, Industry
Communication date: 2019-04-26
Posted date: 2019-05-08
Communication number: 12241-451333 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Michelle Kovacevic, Assistant Deputy Minister | Finance Canada | Finance Canada (FIN)
Subject Matter of the communication: Health, Industry
Communication date: 2019-04-26
Posted date: 2019-05-08
Communication number: 12241-451331 (amended from 12241-451329) View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Francis Scarpaleggia, MP | House of Commons
Subject Matter of the communication: Health, Industry
Communication date: 2019-04-12
Posted date: 2019-05-08
Communication number: 12241-451326 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Paul Halucha, Assistant Secretary to the Cabinet for Privy Council Office | Privy Council Office (PCO)
Subject Matter of the communication: Health, Industry
Communication date: 2019-04-05
Posted date: 2019-05-08
Communication number: 12241-451325 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Sheryl Groeneweg, Director General | Innovation | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Economic Development, Science and Technology
Communication date: 2019-04-02
Posted date: 2019-05-08
Communication number: 12241-451323 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Michelle Kovacevic, Assistant Deputy Minister | Federal-Provincial Relations and Social Policy Branch | Finance Canada (FIN)
- Omar Rajabali, Senior Director, Health, Culture | Housing for Finance Canada | Finance Canada (FIN)
- Daniel Robertson, Senior Project Leader, Social Policy Division | Federal-Provincial Relations and Social Policy Branch | Finance Canada (FIN)
Subject Matter of the communication: Consumer Issues
Communication date: 2019-02-21
Posted date: 2019-03-11
Communication number: 12241-447024 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Dominic Cormier, Policy Advisor | Prime Minister's Office (PMO)
Subject Matter of the communication: Consumer Issues
Communication date: 2019-02-08
Posted date: 2019-03-11
Communication number: 12241-447023 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Bill Morneau, Minister of Finance | Finance Canada | Finance Canada (FIN)
- Ben Chin, Chief of Staff | Finance Canada | Finance Canada (FIN)
Subject Matter of the communication: Health, Industry, Intellectual Property, Internal Trade, Science and Technology
Communication date: 2019-01-25
Posted date: 2019-02-14
Communication number: 12241-445253 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Sheryl Groeneweg, Director General | Innovation, Science and Economic Development Canada | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Consumer Issues
Communication date: 2019-01-21
Posted date: 2019-02-14
Communication number: 12241-445251 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Ben Chin, Chief of Staff | Finance Canada | Finance Canada (FIN)
- Dev Saxena, Senior Policy Advisor | Finance Canada | Finance Canada (FIN)
Subject Matter of the communication: Consumer Issues
Communication date: 2019-01-21
Posted date: 2019-02-14
Communication number: 12241-445246 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Rick Theis, Chief of Staff | Indigenous and Northern Affairs Canada | Prime Minister's Office (PMO)
- Mathieu Bouchard, Senior Advisor | PMO-CPM | Prime Minister's Office (PMO)
- Dominic Cormier, Policy Advisor | PMO-CPM | Prime Minister's Office (PMO)
Subject Matter of the communication: Consumer Issues
Communication date: 2019-01-18
Posted date: 2019-02-14
Communication number: 12241-445234 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Rick Theis, Policy Advisor | Prime Minister's Office (PMO)
- Kathryn Nowers, Director of Policy | Health Canada (HC)
- Hilary Travis, Policy Advisor | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health
Communication date: 2018-08-16
Posted date: 2018-09-17
Communication number: 12241-433987 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Rick Theis, Policy Advisor | Prime Minister's Office (PMO)
Subject Matter of the communication: Health
Communication date: 2018-08-09
Posted date: 2018-09-17
Communication number: 12241-433986 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Kim Elmslie, Assistant Deputy Minister | Infectious Disease Prevention and Control Branch | Public Health Agency of Canada (PHAC)
- Gianluca Cairo, Chief of Staff | Minister of Innovation, Science and Economic Development | Innovation, Science and Economic Development Canada (ISED)
- Hilary Travis, Special Assistant (Policy) | Minister of Innovation, Science and Economic Development | Innovation, Science and Economic Development Canada (ISED)
- Travis Gordon, Policy Advisor | Minister of Health | Health Canada (HC)
Subject Matter of the communication: Health
Communication date: 2018-03-08
Posted date: 2018-07-03
Communication number: 12241-429937 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Kathryn Nowers, Director Policy | Minister of Health Office | Health Canada (HC)
Subject Matter of the communication: Health
Communication date: 2018-03-06
Posted date: 2018-07-03
Communication number: 12241-429939 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Hilary Travis, Special Assistant, Policy and Parvinder Sachdeva, Policy Advisor | Office of the Minister of Innovation | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health
Communication date: 2018-03-06
Posted date: 2018-07-03
Communication number: 12241-429938 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Mathieu Bouhcard, Senior Advisor | Priminister's Office | Prime Minister's Office (PMO)
- Maxime Dea, Policy Advisor | Prime Minister's Office | Prime Minister's Office (PMO)
Subject Matter of the communication: Health
Communication date: 2018-01-30
Posted date: 2018-07-03
Communication number: 12241-429941 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Ramez Ayoub, Member of Parliament | Canadian Liberal Politician Thérèse-De Blainville in the House of Commons of Canada | House of Commons
Subject Matter of the communication: Health
Communication date: 2018-01-25
Posted date: 2018-07-03
Communication number: 12241-429940 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Navdeep Bains, Minister of Innovation | Science and Economic Development | Innovation, Science and Economic Development Canada (ISED)
- A. Gianluca Cairo, Chief of Staff | Office of the Minister of Innovation, Science and Economic Development | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health
Communication date: 2018-01-23
Posted date: 2018-07-03
Communication number: 12241-429942 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Kathryn Nowers, Policy Advisor, Office of the Minister of Health | House of Commons
Subject Matter of the communication: Health
Communication date: 2017-10-30
Posted date: 2017-12-14
Communication number: 12241-416181 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Maxime Dea, Policy Advisor, Office of the prime Minister | House of Commons
Subject Matter of the communication: Health
Communication date: 2017-10-30
Posted date: 2017-12-14
Communication number: 12241-416178 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Francis Scarpaleggia, Member of Parliment | House of Commons
Subject Matter of the communication: Health
Communication date: 2017-10-30
Posted date: 2017-12-14
Communication number: 12241-416176 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Catherine Parker, Director General, Biologics and Genetic Therapies Directorate | Health Canada (HC)
Subject Matter of the communication: Health
Communication date: 2017-10-10
Posted date: 2017-12-14
Communication number: 12241-416172 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Andrew Scheer, Honourable Leader of the Opposition | House of Commons
Subject Matter of the communication: Health
Communication date: 2017-10-05
Posted date: 2017-12-14
Communication number: 12241-416167 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Steve Verheul, Chief Trade Negotiator | CETA | Global Affairs Canada (GAC)
Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
Communication date: 2017-01-30
Posted date: 2017-02-15
Communication number: 12241-393780 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Simon Kennedy, Deputy Minister | Health | Health Canada (HC)
Subject Matter of the communication: Health
Communication date: 2016-10-04
Posted date: 2016-11-15
Communication number: 12241-388397 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Jesse Kancir, Policy Advisor | Health Canada (HC)
Subject Matter of the communication: Health
Communication date: 2016-08-31
Posted date: 2016-10-05
Communication number: 12241-384537 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Christopher Berzins, Director of Policy | Global Affairs Canada (GAC)
- Vincent Garneau, Director of Parliamentary Affairs | Global Affairs Canada (GAC)
Subject Matter of the communication: Intellectual Property, International Trade, Science and Technology, Research and Development
Communication date: 2016-05-06
Posted date: 2016-06-15
Communication number: 12241-379728 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Francis Scarpallagia, MP | House of Commons
Subject Matter of the communication: Regional Development
Communication date: 2015-12-11
Posted date: 2016-01-13
Communication number: 12241-366414 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Simon Kennedy, Deputy Minister | Health Canada (HC)
- Paul Glover, ADM | Health Canada (HC)
Subject Matter of the communication: Health, Economic Development, Research and Development
Communication date: 2015-07-15
Posted date: 2015-08-21
Communication number: 12241-360322 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- John Knubley, Deputy Minister | House of Commons
Subject Matter of the communication: Economic Development
Communication date: 2015-06-16
Posted date: 2015-07-15
Communication number: 12241-358217 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Christian Paradis, Minister of International Development | Foreign Affairs, Trade and Development Canada
Subject Matter of the communication: Regional Development
Communication date: 2014-11-05
Posted date: 2014-12-15
Communication number: 12241-341990 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Paul R. Samson, Assistant Deputy Minister | Foreign Affairs, Trade and Development Canada
- Lois Brown, Parliamentary Secretary to the Minister of International Development | Foreign Affairs, Trade and Development Canada
Subject Matter of the communication: Regional Development
Communication date: 2014-11-04
Posted date: 2014-12-15
Communication number: 12241-341986 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Peter Kent, Progressive Conservative Member of Parliament | House of Commons
Subject Matter of the communication: Health
Communication date: 2014-09-25
Posted date: 2014-10-15
Communication number: 12241-335916 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Ed Holder, Minister of State, Science & Technology | Industry Canada
Subject Matter of the communication: Science and Technology
Communication date: 2014-05-29
Posted date: 2014-06-13
Communication number: 12241-327659 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- James Moore, Minister | Industry | Industry Canada
Subject Matter of the communication: Economic Development
Communication date: 2014-04-29
Posted date: 2014-05-05
Communication number: 12241-323589 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Bob Dechert, Parliament Secretary | House of Commons
Subject Matter of the communication: Economic Development
Communication date: 2013-10-29
Posted date: 2013-11-15
Communication number: 12241-303972 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Françoise Ducro, Assistant Deputy Minister | Aboriginal Affairs and Northern Development Canada
Subject Matter of the communication: Economic Development, Aboriginal Affairs
Communication date: 2013-07-17
Posted date: 2013-08-13
Communication number: 12241-286049 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Kennedy Simon, Deputy Minister International Trade | Foreign Affairs and International Trade Canada (DFAITC)
Subject Matter of the communication: International Trade
Communication date: 2013-05-30
Posted date: 2013-06-14
Communication number: 12241-277299 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Ogilvie Kelvin, Senator | Senate of Canada
Subject Matter of the communication: Health
Communication date: 2013-05-30
Posted date: 2013-06-14
Communication number: 12241-277293 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Paul Glover, Assistant Deputy Minister | Health Products and Food Branch | Health Canada (HC)
- Marta Morgan, Assistant Deputy Minister | Industry Canada
- Philip Jennings, Associate Assistant Deputy Minister | Industry Canada
- Drew Campbell, Stakeholder Relations | Prime Minister's Office (PMO)
- Phil Harwood, Health Policy Advisor | Prime Minister's Office (PMO)
Subject Matter of the communication: Health, Government Procurement
Communication date: 2012-09-18
Posted date: 2012-10-12
Communication number: 12241-240750 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Christian Paradis, MINISTER OF INDUSTRY | Industry Canada
- Sean O'Leary, Policy Advisor | Industry Canada
- Margaux Stastny, Communication Director | Industry Canada
Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
Communication date: 2012-08-27
Posted date: 2012-09-13
Communication number: 12241-236411 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- sean O'Leary, Policy Advisor to Minister of Industry | Industry Canada
Subject Matter of the communication: Industry
Communication date: 2012-07-25
Posted date: 2012-08-13
Communication number: 12241-233371 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Rainer Englehardt, Assistant Deputy Minister | Public Health Agency of Canada (PHAC)
Subject Matter of the communication: Health
Communication date: 2012-06-29
Posted date: 2012-07-12
Communication number: 12241-230213 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Philip Jennings, Associate Assistant Deputy Minister | Industry Sector | Industry Canada
- Aillish Campbell, Director | General Life Sciences Branch | Industry Canada
Subject Matter of the communication: Economic Development, Research and Development
Communication date: 2012-06-18
Posted date: 2012-07-12
Communication number: 12241-230227 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Stella Ambler, MP Mississauga South | House of Commons
Subject Matter of the communication: Economic Development
Communication date: 2012-06-06
Posted date: 2012-07-12
Communication number: 12241-230216 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Ron Cannan, Conservative Member of Parliament | Members of the House of Commons
Subject Matter of the communication: International Relations
Communication date: 2011-10-27
Posted date: 2011-11-15
Communication number: 12241-194859 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Ed Holder, Conservative Member of Parliament | Members of the House of Commons
Subject Matter of the communication: International Trade
Communication date: 2011-10-27
Posted date: 2011-11-15
Communication number: 12241-194857 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Sean Speer, Senior Health Policy Advisor | Prime Minister's Office (PMO)
Subject Matter of the communication: Health
Communication date: 2011-09-21
Posted date: 2011-10-16
Communication number: 12241-188769 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Rachel Curren, Senior Finance Policy Advisor | Prime Minister's Office (PMO)
Subject Matter of the communication: Health
Communication date: 2011-09-21
Posted date: 2011-10-16
Communication number: 12241-188768 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Hedy Fry, Liberal Health Critic | Members of the House of Commons
Subject Matter of the communication: Health
Communication date: 2011-09-21
Posted date: 2011-10-16
Communication number: 12241-188766 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Angela Rickman, Opposition Leader's (NDP) Senior Policy Analyst | Members of the House of Commons
Subject Matter of the communication: Health
Communication date: 2011-09-21
Posted date: 2011-10-16
Communication number: 12241-188763 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Doug Smith, Chief of Staff Minister of Labour | Members of the House of Commons
Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
Communication date: 2011-08-25
Posted date: 2011-09-14
Communication number: 12241-185530 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Francis Scarpallaggia, MP Lac St-Louis | Liberal
Subject Matter of the communication: Health
Communication date: 2011-03-02
Posted date: 2011-04-12
Communication number: 12241-170411 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Kirsty Duncan, Member of Parliament | Liberal
Subject Matter of the communication: Health
Communication date: 2010-11-25
Posted date: 2010-12-15
Communication number: 12241-162114 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Terry Mercer, Senator | Liberal
Subject Matter of the communication: Health
Communication date: 2010-11-24
Posted date: 2010-12-15
Communication number: 12241-162116 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Kelvin Ogilvie, Senator | Conservative
Subject Matter of the communication: Health
Communication date: 2010-11-23
Posted date: 2010-12-15
Communication number: 12241-162115 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Colin Carrie, Member of Parliament | Conservative
Subject Matter of the communication: Health
Communication date: 2010-11-22
Posted date: 2010-12-15
Communication number: 12241-162112 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Mike Wallace, Member of Parliament | Conservative
Subject Matter of the communication: Health
Communication date: 2010-11-16
Posted date: 2010-12-15
Communication number: 12241-162107 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Tim Uppal, Member of Parliament | Conservative
Subject Matter of the communication: Health
Communication date: 2010-11-04
Posted date: 2010-12-15
Communication number: 12241-162109 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Patrick Brown, Member of Parliament | Conservative
Subject Matter of the communication: Health
Communication date: 2010-11-03
Posted date: 2010-12-15
Communication number: 12241-162106 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Paul Szabo, Member of Parliament | Liberal
Subject Matter of the communication: Health
Communication date: 2010-11-03
Posted date: 2010-12-15
Communication number: 12241-162105 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Bonnie Crombie, Member of Parliament | Liberal
Subject Matter of the communication: Health
Communication date: 2010-09-21
Posted date: 2010-10-15
Communication number: 12241-157302 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Tim Uppal, Member of Parliament | Conservative
Subject Matter of the communication: Health
Communication date: 2010-09-21
Posted date: 2010-10-15
Communication number: 12241-157301 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Van Kesteren, Member of Parliament | Conservative
Subject Matter of the communication: Health
Communication date: 2010-09-21
Posted date: 2010-10-15
Communication number: 12241-157299 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- John Macallum, Member of Parliament | Liberal
Subject Matter of the communication: Health
Communication date: 2010-09-21
Posted date: 2010-10-15
Communication number: 12241-157298 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Serge Cardin, Deputy | Bloc québécois
Subject Matter of the communication: Health
Communication date: 2010-09-21
Posted date: 2010-10-15
Communication number: 12241-157290 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Paule Brunelle, Deputy | Bloc québécois
Subject Matter of the communication: Health
Communication date: 2010-09-21
Posted date: 2010-10-15
Communication number: 12241-157289 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Robert Bouchard, Deputy | Bloc québécois
Subject Matter of the communication: Health
Communication date: 2010-09-21
Posted date: 2010-10-15
Communication number: 12241-157288 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Robert Carrier, Deputy | Bloc québécois
Subject Matter of the communication: Health
Communication date: 2010-09-21
Posted date: 2010-10-15
Communication number: 12241-157287 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Jean-Yves Laforest, Deputy | Bloc québécois
Subject Matter of the communication: Health
Communication date: 2010-09-21
Posted date: 2010-10-15
Communication number: 12241-157286 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- R. Engelhart, Assistant Deputy Minister | Public Health Agency of Canada (PHAC)
Subject Matter of the communication: Health
Communication date: 2010-06-03
Posted date: 2010-12-03
Communication number: 12241-161036 (amended from 12241-152219) View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Karen Dodds, ADM | Strategic Policy Branch | Health Canada (HC)
Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade, Science and Technology
Communication date: 2010-05-31
Posted date: 2010-06-10
Communication number: 12241-149959 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Ron Parker, Senior ADM | Industry Sector | Industry Canada
Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade, Science and Technology
Communication date: 2010-05-31
Posted date: 2010-06-10
Communication number: 12241-149958 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Catherine MacLeod, Associate Assistant Deputy Minister | Health Canada (HC)
Subject Matter of the communication: Industry
Communication date: 2010-05-26
Posted date: 2010-06-10
Communication number: 12241-149960 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Dave Forestell, Policy Advisor, Policy and Policy Division | Prime Minister's Office (PMO)
Subject Matter of the communication: Health
Communication date: 2010-02-24
Posted date: 2010-03-22
Communication number: 12241-144096 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Leah Canning, Director of Policy | Health Canada (HC)
Subject Matter of the communication: National Immunization Strategy Program Funding
Communication date: 2010-01-26
Posted date: 2010-02-05
Communication number: 12241-137537 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Stella Ambler, Director, Ontario Regional Affairs | Finance Canada (FIN)
Subject Matter of the communication: National Immunization Strategy Program Funding
Communication date: 2010-01-11
Posted date: 2010-02-05
Communication number: 12241-137434 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Clarke Olson, Policy Advisor | Health Canada (HC)
- Graham Howell, Policy Advisor | Health Canada (HC)
Subject Matter of the communication: Federal Funding
Communication date: 2009-10-01
Posted date: 2009-11-04
Communication number: 12241-127374 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Cameron Adamson, Policy Advisor | Prime Minister's Office (PMO)
Subject Matter of the communication: Health, Industry, Intellectual Property, Science and Technology, Taxation and Finance
Communication date: 2009-06-04
Posted date: 2009-07-15
Communication number: 12241-113873 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Tony Clement, Minister of Health | Public Health Agency of Canada (PHAC)
Subject Matter of the communication: Health, Industry, Intellectual Property, Science and Technology, Taxation and Finance
Communication date: 2009-05-18
Posted date: 2009-06-10
Communication number: 12241-108754 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Meena Ballantyne, Assistant Deputy Minister | Health Products and Food Branch | Health Canada (HC)
Subject Matter of the communication: Health, Science and Technology
Communication date: 2009-03-25
Posted date: 2009-04-15
Communication number: 12241-101094 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- David Butler-Jones, Chief Public Health Officer of Canada | Public Health Agency of Canada (PHAC)
Subject Matter of the communication: Health
Communication date: 2009-03-11
Posted date: 2009-04-15
Communication number: 12241-101097 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Helena Guergis, Minister of State | Status of Women Canada | Status of Women Canada (SWC)
Subject Matter of the communication: Women in Politics
Communication date: 2009-02-04
Posted date: 2009-03-12
Communication number: 12241-97194 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Rodney MacDonald, Policy Advisor | Industry Canada
Subject Matter of the communication: Science and Technology
Communication date: 2009-01-23
Posted date: 2009-02-16
Communication number: 12241-92737 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Benoit Violette, Senior Policy Advisory | Minister's Office | Industry Canada
Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade, Science and Technology, Consumer Issues, Taxation and Finance
Communication date: 2009-01-19
Posted date: 2009-02-16
Communication number: 12241-92738 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Alanna Heath, Policy Advisor | Finance Canada (FIN)
Subject Matter of the communication: Science and Technology
Communication date: 2009-01-08
Posted date: 2009-02-16
Communication number: 12241-92736 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Ted Menzies, MP- Parliamentary Secretary | Finance Canada (FIN)
Subject Matter of the communication: Science and Technology
Communication date: 2009-01-08
Posted date: 2009-02-16
Communication number: 12241-92735 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Leona Aglukkaq, Minister of Health | Health Canada (HC)
Subject Matter of the communication: Health, Industry, Intellectual Property, Science and Technology, Consumer Issues
Communication date: 2009-01-07
Posted date: 2009-02-16
Communication number: 12241-92739 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Amy Ringdahl, Policy Advisory | Office of the Minister of Finance | Finance Canada (FIN)
Subject Matter of the communication: Health, Industry, Intellectual Property, Science and Technology, Consumer Issues, Taxation and Finance
Communication date: 2008-12-04
Posted date: 2009-01-16
Communication number: 12241-89902 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- David Rancourt, Policy Advisory | Office of the Minister of Finance | Finance Canada (FIN)
Subject Matter of the communication: Health, Industry, Intellectual Property, Science and Technology, Consumer Issues, Taxation and Finance
Communication date: 2008-12-04
Posted date: 2009-01-16
Communication number: 12241-89899 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Benoit Violette, Policy Advisor | Industry Canada
Subject Matter of the communication: Industry
Communication date: 2008-11-27
Posted date: 2008-12-16
Communication number: 12241-87374 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Brien Benoit, Chairman of the Board of Directors | Patented Medicine Prices Review Board | Health Canada (HC)
Subject Matter of the communication: Health, Industry, Science and Technology, Consumer Issues
Communication date: 2008-10-21
Posted date: 2008-11-04
Communication number: 12241-84314 View associated registration

Marwan Akar, PRESIDENT (Corporation)

Learn more...

Results below are sorted by posted date, beginning with the most recent.

Results 1-194 of 194

Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Blaine Calkins, Member of Parliament | House of Commons
Subject Matter of the communication: Health, Industry, Research and Development
Communication date: 2024-05-25
Posted date: 2024-06-14
Communication number: 12241-607736 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Tom Kmiec, Member of Parliament | House of Commons
Subject Matter of the communication: Health, Industry, Research and Development
Communication date: 2024-05-24
Posted date: 2024-06-14
Communication number: 12241-607735 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Dr. Stephen Ellis, Member of Parliament | House of Commons
Subject Matter of the communication: Health, Industry, Research and Development
Communication date: 2024-05-23
Posted date: 2024-06-14
Communication number: 12241-607734 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Marilou McPhedran, Senator | Senate of Canada
Subject Matter of the communication: Health, Industry, Research and Development
Communication date: 2024-05-22
Posted date: 2024-06-14
Communication number: 12241-607737 View associated registration
Merck Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Rodrigo Arancibia, Director | Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Industry, Research and Development
Communication date: 2024-04-04
Posted date: 2024-05-13
Communication number: 12241-602791 View associated registration

Date Modified:: 2024-04-04

Search and menus

Language selection

Registration - In-house Corporation

Merck Canada Inc. / Marwan Akar, PRESIDENT

Registration Information

Associated Communications

Version 11 of 43 (2009-11-02 to 2010-04-14)

Version 11 of 43 (2009-11-02 to 2010-04-14)

Subject Matters

Subject matters added through a monthly communication report

Subject Matter Details

Legislative Proposal, Bill or Resolution

Policies or Program

Policies or Program, Regulation

Regulation

Communication Techniques

Government Institutions

Description of activities

Responsible officer name and position during the period of this registration

Government funding

In-house Corporation Contact Information

Parent Company Information

Subsidiary Beneficiary Information

Senior Officers whose lobbying activities represent less than 20% of their Duties

Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties